Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD

Published On 2022-01-07 04:00 GMT   |   Update On 2022-01-07 04:00 GMT

New Delhi: Medical device maker Stryker Corp said on Thursday it had agreed to acquire digital care platform Vocera Communications Inc (VCRA.N) for about $2.97 billion.

Vocera shares were up nearly 27% at $78.63 before the bell, just shy of the offer price of $79.25 per share.

Also Read:IPC issues safety alerts on medical devices including Cranial Perforator, Orthopedic drill

Founded in 2000, Vocera caters to nearly 1,900 hospitals, allowing healthcare workers to communicate and collaborate with co-workers and engage with patients and their families.

The deal is expected to close in the first quarter of this year and is estimated to have a neutral impact on net earnings per diluted share in 2022, Stryker said.

Stryker shares were down nearly 1% at $270 in light premarket trading.

Also Read:Govt approves 8 more device manufacturers under PLI scheme for Medical Devices

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News